Inhibition of bromodomain extraterminal histone readers alleviates skin fibrosis in experimental models of scleroderma
Binding of the bromodomain and extraterminal domain proteins (BETs) to acetylated histone residues is critical for gene transcription. We sought to determine the antifibrotic efficacy and potential mechanisms of BET inhibition in systemic sclerosis (SSc). Blockade of BETs was done using a pan-BET in...
Main Authors: | Sirapa Vichaikul, Mikel Gurrea-Rubio, M. Asif Amin, Phillip L. Campbell, Qi Wu, Megan N. Mattichak, William D. Brodie, Pamela J. Palisoc, Mustafa Ali, Sei Muraoka, Jeffrey H. Ruth, Ellen N. Model, Dallas M. Rohraff, Jonatan L. Hervoso, Yang Mao-Draayer, David A. Fox, Dinesh Khanna, Amr H. Sawalha, Pei-Suen Tsou |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Clinical investigation
2022-05-01
|
Series: | JCI Insight |
Subjects: | |
Online Access: | https://doi.org/10.1172/jci.insight.150871 |
Similar Items
-
Functional Characterization of Glycoprotein Nonmetastatic Melanoma Protein B in Scleroderma Fibrosis
by: Pamela J. Palisoc, et al.
Published: (2022-02-01) -
Bromodomain and Extraterminal Proteins as Novel Epigenetic Targets for Renal Diseases
by: Jose Luis Morgado-Pascual, et al.
Published: (2019-11-01) -
Bromodomain and extraterminal (BET) proteins: biological functions, diseases, and targeted therapy
by: Zhi-Qiang Wang, et al.
Published: (2023-11-01) -
Bromodomain and Extraterminal Domain (BET) Protein Inhibition Hinders Glioblastoma Progression by Inducing Autophagy-Dependent Differentiation
by: Mayra Colardo, et al.
Published: (2023-04-01) -
Regulation of Cell Plasticity by Bromodomain and Extraterminal Domain (BET) Proteins: A New Perspective in Glioblastoma Therapy
by: Deborah Gargano, et al.
Published: (2023-03-01)